SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0001193125-19-325174
Filing Date
2019-12-30
Accepted
2019-12-27 20:23:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 14D9/A d860266dsc14d9a.htm SC 14D9/A 18239
  Complete submission text file 0001193125-19-325174.txt   19852
Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Filed by) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Subject) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A | Act: 34 | File No.: 005-89574 | Film No.: 191314662
SIC: 2836 Biological Products, (No Diagnostic Substances)